{
  "buildId": "NSDuYoJl8cxdTqEyCvTi0",
  "gssp": true,
  "isFallback": false,
  "page": "/calc/[...slug]",
  "props": {
    "__N_SSP": true,
    "pageProps": {
      "calc": {
        "before_use": "",
        "calc_type": "",
        "chief_complaint_en": [
          "Cough",
          "Fatigue",
          "Shortness of Breath"
        ],
        "cmeEndDate": null,
        "cmeLastReviewed": null,
        "cmeReleaseDate": null,
        "cme_status": "",
        "content": {
          "about": {
            "evidence_based_medicine_en": "<p><span id=\"docs-internal-guid-89952ac2-7fff-90be-0d86-ee164b9f3e65\">Guidelines for IRAE for lung toxicity (pneumonitis) were developed by a multidisciplinary, multi-organizational panel of experts in medical oncology based on a systematic review of the medical literature.</p>",
            "formula_en": "<div dir=\"ltr\" align=\"left\">\n<table style=\"width: 100%; height: 375px;\"><colgroup><col style=\"width: 83.8473%;\" /><col style=\"width: 16.1527%;\" /></colgroup>\n<tbody>\n<tr style=\"height: 75px;\">\n<td style=\"height: 75px;\">\n<p dir=\"ltr\"><strong>Criteria</strong></p>\n</td>\n<td style=\"height: 75px;\">\n<p dir=\"ltr\"><strong>Pneumonitis grade</strong></p>\n</td>\n</tr>\n<tr style=\"height: 75px;\">\n<td style=\"height: 75px;\">\n<p dir=\"ltr\">Asymptomatic, confined to one lobe of the lung or &lt;25% of lung parenchyma, clinical, or diagnostic observations only</p>\n</td>\n<td style=\"height: 75px;\">\n<p dir=\"ltr\">G1</p>\n</td>\n</tr>\n<tr style=\"height: 75px;\">\n<td style=\"height: 75px;\">\n<p dir=\"ltr\">Symptomatic, involves more than one lobe of the lung or 25-50% of lung parenchyma, medical intervention indicated, limiting instrumental ADL</p>\n</td>\n<td style=\"height: 75px;\">\n<p dir=\"ltr\">G2</p>\n</td>\n</tr>\n<tr style=\"height: 75px;\">\n<td style=\"height: 75px;\">\n<p dir=\"ltr\">Severe symptoms, hospitalization required, involves all lung lobes or &gt;50% of lung parenchyma, limiting self-care ADL, oxygen indicated</p>\n</td>\n<td style=\"height: 75px;\">\n<p dir=\"ltr\">G3</p>\n</td>\n</tr>\n<tr style=\"height: 75px;\">\n<td style=\"height: 75px;\">\n<p dir=\"ltr\">Life-threatening respiratory compromise, urgent intervention indicated (intubation)&nbsp;</p>\n</td>\n<td style=\"height: 75px;\">\n<p dir=\"ltr\">G4</p>\n</td>\n</tr>\n</tbody>\n</table>\n</div>\n<p dir=\"ltr\">See Next Steps for details on management.</p>",
            "more_info_en": "",
            "references_list": {
              "Clinical Practice Guidelines": [],
              "Manufacturer Website": [],
              "Original/Primary Reference": [
                {
                  "href": "https://www.ncbi.nlm.nih.gov/pubmed/29442540 ",
                  "text": "Brahmer JR, Lacchetti C, Schneider BJ, et al. Management of Immune-Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2018;36(17):1714-1768."
                }
              ],
              "Other References": [],
              "Outcomes": [],
              "Validation": []
            }
          },
          "contributor": {
            "expert_name": [
              "Nazli Dizman, MD"
            ]
          },
          "creator": [
            {
              "approved": false,
              "name": "Dr. Julie R. Brahmer",
              "qa_en": ""
            }
          ],
          "how_to_use": {
            "pearls_pitfalls_en": "<p><span id=\"docs-internal-guid-c798ed6a-7fff-5952-080b-528985ebfa9d\"></p>\n<ul>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Immune checkpoint inhibitor (ICPi) pneumonitis should be suspected in patients with symptoms of pneumonitis (cough, wheezing, fatigue, chest pain) or those with focal or diffuse inflammation of the lung parenchyma, typically identified on CT imaging while on treatment with immune checkpoint inhibitors.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Immune checkpoint inhibitor (ICPi) pneumonitis is an uncommon but potentially serious toxicity.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">May occur any time during immune checkpoint inhibitor treatment with a range of 2-24 months. Median time to onset is approximately 3 months.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">More frequently seen with anti-PD1 agents, but is also an important adverse event caused by anti-CTLA-4 agents.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Management of immune checkpoint inhibitor pneumonitis is based on the grade of pneumonitis.</p>\n</li>\n</ul>",
            "use_case_en": "<p>Adult patients with symptoms of pneumonitis (cough, wheezing, fatigue, chest pain) or focal or diffuse inflammation of the lung parenchyma while on treatment with immune checkpoint inhibitors including agents against PD-1 (i.e., pembrolizumab, nivolumab), PD-L1 (i.e., atezolizumab, avelumab, durvalumab), or CTLA-4 (i.e., ipilimumab).</p>",
            "why_use_en": "<p><span id=\"docs-internal-guid-5e0c1572-7fff-855d-78d7-cf92047ba136\">ICPi pneumonitis is a rare but potentially life threatening toxicity of immune checkpoint inhibitors. This tool aids in the decision to discontinue ICPI, further diagnostic work-up and immunosuppressant treatment initiation.</p>"
          },
          "next_steps": {
            "advice_en": "<p dir=\"ltr\">Monitor patients for symptoms of pneumonitis and carefully review imaging studies of lung for detection of pneumonitis in asymptomatic patients.&nbsp;</p>\n<p><span id=\"docs-internal-guid-3c86d1a5-7fff-a59a-4d08-b568326a41e9\"></p>\n<p dir=\"ltr\">For grade 2 or higher ICPi pneumonitis may include the following infectious work-up: nasal swab, sputum culture and sensitivity, blood culture and sensitivity, urine culture and sensitivity.</p>",
            "critical_actions_en": "<p dir=\"ltr\">When the clinical picture is consistent with pneumonitis, biopsy is generally unnecessary. However, biopsy may assist to rule out other etiologies such as lymphangitic spread of tumor or infection.</p>\n<p><span id=\"docs-internal-guid-576c43c0-7fff-5330-9d44-f351c4e1b791\"></p>\n<p dir=\"ltr\">The role of prophylactic fluconazole with prolonged corticosteroid use (&gt;12 weeks) remains unclear, and physicians should follow institutional guidelines.</p>",
            "management_en": "<p dir=\"ltr\">For all patients where an IRAE diagnosis is being considered, it is always recommended to involve the specialist or team prescribing the immune checkpoint therapy.&nbsp;</p>\n<p dir=\"ltr\"><strong>Grade 1:</strong></p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Hold ICPi with radiologic evidence of pneumonitis progression.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">May offer repeat CT in 3-4 weeks.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">May offer a repeat spirometry/diffusing capacity of lung for carbon monoxide if the patients had undergone the test on ICPi initiation.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">May resume ICPi if improved or resolved radiographically.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If no improvement, treat as grade 2.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Monitor weekly with history and physical examination, pulse oximetry and optional CXR.</p>\n</li>\n</ol>\n<p dir=\"ltr\"><strong>Grade 2:</strong></p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Should hold ICPi until resolution to &le; Grade 1.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider prednisone 1-2 mg/kg/d and taper by 5-10 mg/wk over 4-6 weeks per institutional guidelines.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider bronchoscopy with bronchoalveolar lavage.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider empirical antibiotics.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Monitor every 3 days with history and physical examination, pulse oximetry, consider CXR.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If no improvement in 48-72 hours of prednisone, treat as grade 3.</p>\n</li>\n</ol>\n<p dir=\"ltr\"><strong>Grade 3-4:</strong></p>\n<ol>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Permanently discontinue ICPi.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider empirical antibiotics.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider (methyl)prednisolone IV 1-2 mg/kg/d.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">If no improvement after 48 hours, add infliximab 5 mg/kg or mycophenolate mofetil IV 1 g twice a day or IVIG for 5 days or cyclophosphamide. Taper corticosteroids over 4-6 weeks.&nbsp;</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consult pulmonary and infectious disease if necessary.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Offer bronchoscopy with bronchoalveolar lavage with or without transbronchial biopsy.</p>\n</li>\n<li dir=\"ltr\" aria-level=\"1\">\n<p dir=\"ltr\" role=\"presentation\">Consider admission for further management.</p>\n</li>\n</ol>\n<p><span id=\"docs-internal-guid-2e3ec5e9-7fff-d411-963b-0063c3d91a87\">See <a href=\"https://www.ncbi.nlm.nih.gov/pubmed/29442540\" target=\"_blank\" rel=\"noopener\">Brahmer 2018</a> for full ASCO guidelines.</p>"
          },
          "related_resources": {
            "guidelines": [],
            "interests": [],
            "mdcalc_rating": [],
            "partner_contact": [],
            "sdm_tool": [],
            "teaching": [],
            "videos": []
          },
          "reviewer": []
        },
        "disease_en": [
          "Pneumonitis"
        ],
        "dosing": false,
        "equation_logic_text": "var calc_output = [];\n\nvar grading = parseFloat(grading);\nvar rec;\n\nswitch (grading) {\n  case 1:\n    rec = 'Hold ICPi temporarily; repeat CT in 3-4 weeks; consider resuming ICPi if improved/resolved radiographically; monitor weekly with H&P, pulse oximetry and optional CXR; treat as grade 2 if no improvement; see Next Steps for details';\n    break;\n  case 2:\n    rec = 'Hold ICPi until resolution to Grade ≤ 1; start prednisone 1-2 mg/kg ; consider bronchoscopy with BAL; consider empirical antibiotics; monitor every 3 days with H&P, pulse oximetry and optional CXR; treat as Grade 3 if no improvement in 48-72 hours; see Next Steps for details';\n    break;\n  case 3:\n    rec = 'Permanently discontinue ICPi; hospitalize the patient; start empirical antibiotics; start (methyl)prednisolone IV 1-2 mg/kg/d; if no improvement after 48h, consider infliximab, mycophenolate mofetil or IVIG; taper steroids over 4-6w; consult pulmonary and infectious diseases if necessary; offer bronchoscopy with BAL ± transbronchial biopsy; see Next Steps for details';\n    break;\n  case 4:\n    rec = 'Permanently discontinue ICPi; hospitalize the patient; start empirical antibiotics; start (methyl)prednisolone IV 1-2 mg/kg/d; if no improvement after 48h, consider infliximab, mycophenolate mofetil or IVIG; taper steroids over 4-6w; consult pulmonary and infectious diseases if necessary; offer bronchoscopy with BAL ± transbronchial biopsy; see Next Steps for details';\n}\n\n//results\ncalc_output.push({\n    name: 'mini',\n    value: 'G'+grading,\n    value_text: '',\n    message: 'Pneumonitis grade'   \n});\ncalc_output.push({\n    name: 'Score',\n    value: 'G'+grading,\n    value_text: '',\n    message: 'Pneumonitis grade'   \n});\ncalc_output.push({\n    name: 'risk1',\n    value: '', \n    value_text: '',\n    message: rec\n});\n",
        "favorite_id": 10383,
        "full_title_en": "Immune-Related Adverse Events for Lung Toxicity - Pneumonitis",
        "input_schema": [
          {
            "conditionality": "",
            "default": null,
            "label_en": "Criteria",
            "name": "grading",
            "optional": false,
            "options": [
              {
                "label": "Asymptomatic, confined to one lobe of the lung or <25% of lung parenchyma, clinical, or diagnostic observations only",
                "value": 1
              },
              {
                "label": "Symptomatic, involves more than one lobe of the lung or 25-50% of lung parenchyma, medical intervention indicated, limiting instrumental ADL",
                "value": 2
              },
              {
                "label": "Severe symptoms, hospitalization required, involves all lung lobes or >50% of lung parenchyma, limiting self-care ADL, oxygen indicated",
                "value": 3
              },
              {
                "label": "Life-threatening respiratory compromise, urgent intervention indicated (intubation) ",
                "value": 4
              }
            ],
            "show_points": false,
            "tips_en": "",
            "type": "radio"
          }
        ],
        "instructions_en": "<p>Use in adult patients with symptoms of pneumonitis or focal or diffuse inflammation of the lung parenchyma typically identified on CT imaging while on treatment with immune checkpoint inhibitors.</p>",
        "logs": [
          {
            "message": "fixed typo",
            "time": "2021-06-04T16:27:00.000Z",
            "user": "sang"
          },
          {
            "message": "edited content",
            "time": "2021-05-25T10:26:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "results",
            "time": "2021-05-04T10:30:00.000Z",
            "user": "michael"
          },
          {
            "message": "edited content",
            "time": "2021-04-29T21:58:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edits",
            "time": "2021-04-27T01:28:00.000Z",
            "user": "lubaina"
          },
          {
            "message": "added input",
            "time": "2021-04-25T00:16:00.000Z",
            "user": "lubaina"
          },
          {
            "message": "added tag",
            "time": "2021-04-05T17:08:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "edited content",
            "time": "2021-04-05T17:07:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "added content",
            "time": "2021-04-05T17:06:00.000Z",
            "user": "tiffany"
          },
          {
            "message": "created calc",
            "time": "2021-04-05T17:03:00.000Z",
            "user": "tiffany"
          }
        ],
        "md5": "",
        "medium_description_en": "<p>Grades severity of pneumonitis secondary to immune checkpoint inhibitor therapy.</p>",
        "purpose_en": [
          "Diagnosis",
          "Prognosis"
        ],
        "search_abbreviation_en": [
          "Immune Related Adverse Events, irae, pneumonitis, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO"
        ],
        "search_id": "c-10383",
        "seo": {
          "keywords_en": "Immune Related Adverse Events, irae, pneumonitis, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO",
          "meta_description_en": "The Immune-Related Adverse Events for Lung Toxicity - Pneumonitis grades severity of pneumonitis secondary to immune checkpoint inhibitor therapy."
        },
        "short_description_en": "Pneumonitis severity (ICPi therapy).",
        "short_title_en": "IRAE for Lung Toxicity - Pneumonitis",
        "slug": "immune-related-adverse-events-lung-toxicity-pneumonitis",
        "specialty_en": [
          "Allergy and Immunology",
          "Hospitalist Medicine",
          "Internal Medicine",
          "Pulmonology"
        ],
        "system_en": [
          "Respiratory"
        ]
      },
      "contributors": [
        {
          "contributors_page": false,
          "createdAt": "2021-12-22T21:20:30.365Z",
          "description": "",
          "firstName": "Nazli",
          "hasDisclosure": [],
          "img": "",
          "lastName": "Dizman",
          "name": "Nazli Dizman, MD",
          "publishedAt": "2021-11-17T15:11:30.452Z",
          "signedCOI": true,
          "status": null,
          "target": "",
          "updatedAt": "2021-11-17T15:11:35.298Z"
        }
      ],
      "creators": [
        {
          "about_en": "<p>Julie R. Brahmer, MSc, MD, is the co-director of the upper aerodigestive department at Johns Hopkins Medicine in Baltimore, MD. She is also a professor of oncology at Johns Hopkins Medicine. Dr. Brahmer’s primary research is focused on treatment of lung cancer and mesothelioma.</p>",
          "createdAt": "2021-12-23T18:03:17.779Z",
          "deceased": null,
          "firstName": "",
          "lastName": "",
          "name": "Dr. Julie R. Brahmer",
          "photo_en": "https://cdn-web-img.mdcalc.com/people/dr-julie-brahmer.png",
          "publishedAt": "2021-11-17T15:11:30.452Z",
          "pubmedLink": "https://www.ncbi.nlm.nih.gov/pubmed/?term=Brahmer+JR%5BAuthor%5D",
          "signedCOI": false,
          "updatedAt": "2021-11-17T15:11:35.298Z"
        }
      ],
      "envs": {
        "CANONICAL_URL_ROOT": "https://www.mdcalc.com",
        "RECAPTCHA_PUBLIC_KEY": "6Lcu1mMkAAAAAAwmSDO3I7JNaUo9YtZ3jnrzTP6a",
        "STRAPI_TAG": "WEB_PROD",
        "STRIPE_PUB_KEY": "pk_live_yYm2UzDzaudhFgqWcKbv9vH7"
      },
      "faqs": [
        {
          "cme_faq": {
            "answer": "<p>MDCalc&rsquo;s Continuing Medical Education (CME) service allows users to easily earn AMA PRA Category 1 CreditsTM through regular use of MDCalc. Simply put, on top of getting the best medical calculators in the world, your usage will help you achieve your annual CME requirements, including specialty CME, without any extra effort.</p>",
            "createdAt": "2022-12-16T16:39:54.990Z",
            "publishedAt": "2022-12-16T16:39:55.697Z",
            "question": "What is MDCalc CME?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:52:48.348Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Yes, in support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and MDCalc Ltd. Inc. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.</p>",
            "createdAt": "2022-12-16T16:40:11.179Z",
            "publishedAt": "2022-12-16T16:40:11.883Z",
            "question": "Is MDCalc CME accredited?",
            "type": "Using",
            "updatedAt": "2023-02-09T18:38:00.345Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Only United States attending physicians, nurse practitioners, nurses, and physician assistants are eligible for our CME service.</p>",
            "createdAt": "2022-12-16T16:40:27.936Z",
            "publishedAt": "2022-12-16T16:40:28.851Z",
            "question": "Who can enroll and how?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:12.659Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>We have over 275 CME-eligible calculators across various specialties. You can read the clinical content supporting any CME calculators to start earning. Once you have viewed all the supporting content for a calculator, you will have officially earned the credit amount (0.5 credits) and will be able to redeem a certificate. For now, only calc content in CME-eligible calcs is eligible for CME credits, however, we&rsquo;ll be expanding our CME service to include more of our content in the future.</p>",
            "createdAt": "2022-12-16T16:40:47.203Z",
            "publishedAt": "2022-12-16T16:40:47.882Z",
            "question": "What activities can I do to earn CME credits?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:27.268Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Simply use our search bar or visit our homepage to easily find CME-eligible calcs. You must be enrolled in our CME service to see which calcs are CME-eligible.</p>",
            "createdAt": "2022-12-16T16:40:57.420Z",
            "publishedAt": "2022-12-16T16:41:02.863Z",
            "question": "Where can I find calcs with which I can earn credits?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:44.504Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Once you&rsquo;ve enrolled in our CME service, you will have a personal CME Dashboard where you can view all of your earned credits. You can navigate to the dashboard by clicking the CME button in the header at the top of any page.</p>",
            "createdAt": "2022-12-16T16:41:11.874Z",
            "publishedAt": "2022-12-16T16:41:13.038Z",
            "question": "Where can I see which credits I’ve earned?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:53:52.153Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Go to your CME Dashboard and select the credits you&rsquo;d like to redeem, fill out a few dropdown answers about how you used the calc, and then proceed to checkout.</p>",
            "createdAt": "2022-12-16T16:41:33.940Z",
            "publishedAt": "2022-12-16T16:41:35.646Z",
            "question": "How do I redeem CME credits?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:54:07.237Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>No. Earning credits as you use calcs is free, but either you (or your employer) will need to purchase an annual subscription to redeem your CME certificates.</p>",
            "createdAt": "2022-12-16T16:41:59.307Z",
            "publishedAt": "2022-12-16T16:42:00.078Z",
            "question": "Are CME credits free?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:54:22.467Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Just like with earned credits, you can view your CME certificates on your CME Dashboard in the &ldquo;CME Certificates&rdquo; tab. Certificates include a list of all of the calcs for which CME was earned along with a tally of the specialty CME.</p>",
            "createdAt": "2022-12-16T16:42:10.712Z",
            "publishedAt": "2022-12-16T16:42:15.215Z",
            "question": "Where can I see my CME certificates?",
            "type": "Using",
            "updatedAt": "2023-01-04T22:54:32.826Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>One year from the date of purchase.</p>",
            "createdAt": "2022-12-16T16:42:52.839Z",
            "publishedAt": "2022-12-16T16:42:53.641Z",
            "question": "How long do credits in an annual subscription last?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:54:51.655Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>General; Addiction and Controlled Substances; Cardiac Care; Domestic and Intimate Partner Violence; Geriatrics; HIV and Infectious Disease; Hospice, End-of-Life, Terminal Illness, and Palliative Care; Mental and Behavioral Health; Pain Management; Pediatrics; Stroke; and Trauma.</p>",
            "createdAt": "2022-12-16T16:32:44.987Z",
            "publishedAt": "2022-12-16T16:32:46.006Z",
            "question": "What specialty CME credits are included in the plan?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:50:33.794Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Your gift card will be sent via email within 1-2 business days of making your purchase. You will be able to select from the following options - Visa, Amazon.com, Apple. Be sure to claim your gift card offer within 90 days of receiving the email.</p>\n<p>Your CME purchase may have implications for tax reporting purposes. The cost of your CME product may or may not be tax-deductible when used for professional purposes. Any reimbursed amount for incentives must be declared as personal income for tax purposes. Please consult your tax advisor. MDCalc does not provide tax advice.</p>",
            "createdAt": "2022-12-16T16:33:18.512Z",
            "publishedAt": "2022-12-16T16:33:19.250Z",
            "question": "I ordered a CME package with a gift card. How does it work?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:50:53.878Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Per the new guidelines from ACCME, the receipt will separate the cost you paid into the cost of the gift card and the cost of the CME learning activity.</p>",
            "createdAt": "2022-12-16T16:44:06.809Z",
            "publishedAt": "2022-12-16T16:44:07.518Z",
            "question": "What will show on my receipt for CME when it includes a gift card?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:55:08.549Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can get a refund (minus any promotional gift amount) within 30-days if the ease of earning and redeeming does not meet your expectations and if you have redeemed no more than 4 credits. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request a refund.</p>",
            "createdAt": "2022-12-16T16:36:44.877Z",
            "publishedAt": "2022-12-16T16:36:45.950Z",
            "question": "How do I get a refund if I'm not satisfied?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:51:01.761Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>You can upgrade your subscription throughout your billing cycle and pay the difference for a higher plan. You may request to downgrade your plan to a lower level to coincide with your next renewal. Please email <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> to request changes.</p>",
            "createdAt": "2022-12-16T16:37:26.433Z",
            "publishedAt": "2022-12-16T16:37:27.177Z",
            "question": "How do I later upgrade to a different plan if I need more credits?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:51:27.457Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>Gift card plans are available for 1 year and do not auto-renew. Standard, non gift-card subscriptions are auto-renewed annually. You can disable the automatic renewal of your subscription at any time by emailing <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a>.</p>",
            "createdAt": "2022-12-16T16:44:53.580Z",
            "publishedAt": "2022-12-16T16:44:56.993Z",
            "question": "Do CME plans auto-renew?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:55:44.653Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>If you&rsquo;re part of a team or practice that wants to sign up five or more physicians, please email us at <a href=\"mailto:team@mdcalc.com\" target=\"_blank\" rel=\"noopener\">team@mdcalc.com</a> for more information.</p>",
            "createdAt": "2022-12-16T16:38:26.466Z",
            "publishedAt": "2022-12-16T16:38:27.163Z",
            "question": "How do I get information on a discounted bulk subscription program for my institution, team, or practice?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:51:43.762Z"
          }
        },
        {
          "cme_faq": {
            "answer": "<p>On July 28, 2022, ACCME updated the guidelines regarding the use of high-value incentives. These guidelines allow for the use of gift card rewards in a regulated manner. Visit the ACCME website to read their guidelines.</p>",
            "createdAt": "2022-12-16T16:46:21.538Z",
            "publishedAt": "2022-12-16T16:46:27.759Z",
            "question": "Did the ACCME decide to regulate gift cards?",
            "type": "Purchasing",
            "updatedAt": "2023-01-04T22:56:05.573Z"
          }
        }
      ],
      "headConfig": {
        "canonicalUrl": "/calc/10383/immune-related-adverse-events-lung-toxicity-pneumonitis",
        "description": "The Immune-Related Adverse Events for Lung Toxicity - Pneumonitis grades severity of pneumonitis secondary to immune checkpoint inhibitor therapy.",
        "keywords": "Immune Related Adverse Events, irae, pneumonitis, immune checkpoint inhibitor therapy, ICPi therapy, ASCO guideline, ASCO",
        "title": "Immune-Related Adverse Events for Lung Toxicity - Pneumonitis"
      },
      "isCMECalc": false,
      "measurements": [],
      "relCalcs": [
        {
          "calcId": 10377,
          "short_title_en": "IRAE for Endocrine Toxicities - Diabetes",
          "slug": "immune-related-adverse-events-endocrine-toxicities-diabetes-mellitus"
        },
        {
          "calcId": 10382,
          "short_title_en": "IRAE for Endocrine Toxicities - Hypothyroidism",
          "slug": "immune-related-adverse-events-endocrine-toxicities-hypothyroidism"
        },
        {
          "calcId": 10378,
          "short_title_en": "IRAE for Renal Toxicities - Nephritis",
          "slug": "immune-related-adverse-events-renal-toxicities-nephritis"
        }
      ],
      "societies": {
        "American Association for the Study of Liver Diseases": {
          "abbreviation": "AASLD",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.aasld.org/"
        },
        "American College Of Emergency Physicians": {
          "abbreviation": "ACEP",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/american-college-of-emergency-physicians-squarelogo.png",
          "web_link": "https://www.acep.org/"
        },
        "American College of Gastroenterology": {
          "abbreviation": "ACG",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/acg_logo.png",
          "web_link": "https://gi.org/"
        },
        "American College of Rheumatology": {
          "abbreviation": "ACR",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.rheumatology.org/"
        },
        "American Gastroenterological Association": {
          "abbreviation": "AGA",
          "description": "plain-text",
          "img": "https://apps.mdcalc.com/images/societies/aga.jpeg",
          "web_link": "https://gastro.org"
        },
        "American Heart Association": {
          "abbreviation": "AHA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/apps.mdcalc.com/images/societies/+AHA+(American+Heart+Association).png",
          "target": "aha",
          "web_link": "http://www.heart.org/HEARTORG/"
        },
        "American Urological Association": {
          "abbreviation": "AUA",
          "description": "plain-text",
          "img": "https://s3-us-west-2.amazonaws.com/cdn-web-img.mdcalc.com/logo/other_society.png",
          "web_link": "https://www.auanet.org/"
        },
        "EB Medicine": {
          "abbreviation": "EB Medicine",
          "description": "EB Medicine is the premier provider of evidence-based clinical content and CME resources for emergency medicine practitioners.",
          "img": "https://cdn-web-img.mdcalc.com/other/eb_medicine-icon-only.jpg",
          "target": "eb-medicine",
          "web_link": "http://www.ebmedicine.net/"
        },
        "MDCalc CME": {
          "abbreviation": "MDCalc CME",
          "img": "https://cdn-web-img.mdcalc.com/Stroke-CME-content.jpg",
          "web_link": "https://www.mdcalc.com/stroke-cme?utm_source=NIHSS_calc&utm_medium=NIHSS_calc&utm_campaign=NIHSS_calc"
        },
        "OTHER": {
          "abbreviation": "OTHER"
        },
        "Postgraduate Institute for Medicine": {
          "abbreviation": "PIM",
          "description": "plain-text",
          "img": "https://cdn-web-img.mdcalc.com/PIM-circle-COLOR.jpeg",
          "target": "pim",
          "web_link": "https://www.pimed.com/"
        },
        "VACO Podcast": {
          "description": "Listen to the VACO co-creators break down how to use VACO\\, what it does\\, and what it doesn’t.",
          "img": "https://cdn-web-img.mdcalc.com/content/podcast 2.png",
          "web_link": "https://www.stimuluspodcast.com/post/32-the-covid-mortality-score-vaco"
        }
      },
      "validSections": [
        "whenToUseViewed",
        "pearlsPitfallsViewed",
        "whyUseViewed",
        "nextStepsViewed",
        "evidenceViewed"
      ]
    }
  },
  "query": {
    "slug": [
      "10383",
      "immune-related-adverse-events-lung-toxicity-pneumonitis"
    ]
  },
  "scriptLoader": []
}